Navigation Links
General Patent Corporation Calls New Patent Reform Bill Harmful to Inventors and Entrepreneurs
Date:4/13/2009

General Patent CEO Alexander Poltorak, writing in the syndicated "Washington Watch" column, strongly criticized the proposed Patent Reform Act of 2009 saying that "recycling a piece of failed legislation is not the best way to protect American inventors and spur innovation."

Suffern, N.Y., (PRWEB) - General Patent Corporation chairman and CEO Alexander Poltorak, writing in the popular syndicated "Washington Watch" column circulated throughout the country, strongly criticized the proposed Patent Reform Act of 2009, and said that "recycling a piece of failed legislation is not the best way to protect American inventors and spur innovation."

Calling the proposed new bill "a warmed-over version of a proposed policy package that didn't pass the first time it was introduced in 2007," Dr. Poltorak said "the apportionment of damages and other changes would weaken patents and make it easier for offshore copycats to bring pirated goods into the U.S. This," he continued, "could have serious consequences for American jobs and the country's competitiveness in the global economy."

The proposed changes would transform the U.S. system for granting patents from a "first-to-invent" basis to the European-style "first-to-file" system, which would lead to a "race to the Patent Office" that favors large corporations over small inventors.

"Many critics," Dr. Poltorak said, believe the proposed changes as currently written "will diminish many of the protections offered by the current law and discourage innovation and venture investment, and make it even more difficult to enforce a patent."

Dr. Poltorak's company, General Patent Corporation, has for the past 22 years assisted inventors and entrepreneurs with licensing and enforcement of their patents, and helped them protect their intellectual rights and property under the law.

Dr. Poltorak, a national expert on the U.S. patent system and co-author of two books on the subject, says that the new bill "will devalue patents, and stifle innovation and entrepreneurship." He is also founder and president of the non-profit organization American Innovators for Patent Reform (AIPR), and suggests that readers write to their respective Senators and Congressional Representatives to express their views about the Patent Reform Act of 2009.

For further information, contact General Patent Corporation at www.generalpatent.com, telephone 845-368-4000 x116.

About General Patent Corporation
General Patent Corporation (GPC), headquartered in Suffern, New York, is the premier intellectual property (IP) boutique focusing on patent licensing and patent enforcement, as well as IP strategy and IP valuation. GPC represents clients in assertive licensing, patent infringement claims and patent infringement litigation on a contingency basis. For more information, visit www.generalpatent.com.

###

Read the full story at http://www.prweb.com/releases/patent-infringement/patent-enforcement/prweb2316384.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Vancouver General Hospital is the First Canadian Institution to Implement Copan WASP(R): Walk-Away Specimen Processor
2. Champions Biotechnology, Inc. Establishes UK Subsidiary and Retains General Manager to Expand Its Personalized Oncology Business
3. Microbia, Inc. Names Mike Doyle as Senior Vice President and General Manager, Nutrition Ingredients
4. Extraordinary General Meetings Statement -- XTL Also Announces Board and Management Changes
5. Spiral Biotech to Introduce New Autoplate Spiral Plating System at ASM General Meeting in May
6. XTL Biopharmaceuticals Ltd. Extraordinary General Meetings Postponed Until March 18, 2009
7. New General Manager, Transition to New Raleigh Offices Highlight Datatrials Expansion of North American Operations
8. Cephalon Appoints Sarma P. Duddu as General Manager and Vice President of Drug Delivery Technologies for CIMA LABS
9. Martek, General Mills Collaborate on Microencapsulation Technology for Food Applications
10. Lafayette General Medical Center is the First Hospital in Louisiana to Use Genetic-Based Technology to Test for Respiratory Disease
11. Senetek PLC Announces 2008 Annual General Meeting Voting Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2016)... ... May 19, 2016 , ... KCAS ... welcomed Abu Siddiqui as Director, Large Molecule & Biomarker Bioanalysis. , Dr. Siddiqui ... translational biomarker discovery studies for preclinical and clinical safety programs. “We’ve seen significant ...
(Date:5/18/2016)... 18, 2016 The Biotech industry continues ... mean that there are no opportunities ahead. Today, ActiveWallSt.com has ... THLD ), Seattle Genetics Inc. (NASDAQ: ... Ophthotech Corp. (NASDAQ: OPHT ). Sign up now ... http://www.activewallst.com/ Threshold Pharmaceuticals Inc.,s shares ...
(Date:5/17/2016)... , May 18, 2016 Haselmeier ... prefilled pen following approval by EMA, the European Medicines ... science and technology company, the new pen version includes ... increased level of confidence to patients during use. ... prefilled pen easier to handle with a larger display ...
(Date:5/17/2016)... Switzerland , May 17, 2016 ... company located in Basel, Switzerland ... investigational oral inhibitor of P38 mitogen-activated protein kinase. ... , Strekin will build the necessary ... in indications in which MAP Kinases play fundamental ...
Breaking Biology Technology:
(Date:5/20/2016)... , May 20, 2016  VoiceIt is ... partnership with VoicePass. By working together, ... experience.  Because VoiceIt and VoicePass take slightly different ... engines increases both security and usability. ... excitement about this new partnership. "This ...
(Date:5/9/2016)... Elevay is currently known as ... for high net worth professionals seeking travel for work ... world, there is still no substitute for a face-to-face ... your deal with a firm handshake. This is why ... of citizenship via investment programs like those offered by ...
(Date:4/28/2016)... April 28, 2016 First quarter 2016:   ... 966% compared with the first quarter of 2015 The ... 589.1 M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) ... guidance is unchanged, SEK 7,000-8,500 M. The operating margin ...
Breaking Biology News(10 mins):